Samsung Medical Center
Seoul, 135-710, South Korea
NCT Number: NCT01379352
The vecuronium requirements may be reduced for recipients of living donor liver transplantation, as the vecuronium is eliminated principally by the liver. Furthermore, the requirements may be different according to the phase of surgery. The requirements may also be different according to the preoperative hepatic function as measured by MELD score during prehepatic phase, or graft to recipient body weight ratio (GRWR) during neohepatic phase. Therefore, the investigators are trying to investigate the difference of vecuronium requirements according to the phase of surgery or MELD score, GRWR.
Looking for future studies?
Notify Me20 year–69 year
All sexes
Observational
Seoul, 135-710, South Korea
The vecuronium requirements may be reduced for recipients of living donor liver transplantation, as the vecuronium is eliminated principally by the liver. Furthermore, the requirements may be different according to the phase of surgery. The requirements may by further reduced during anhepatic phase of liver transplantation. And the requirements may be increased as the graft functions during neohepatic phase.
We also postulated that the requirements may be different according to the preoperative hepatic function during preanhepatic phase, and according to the graft to recipient body weight ratio (GRWR) during neohepatic phase.
Therefore, we are trying to investigate the difference of vecuronium requirements according to the phase of surgery, MELD score, GRWR.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: during prehepatic phase of liver transplantation
total vecuronium requirements as guided by Train-of-four neuromuscular monitoring during preanhepatic phase
Time frame: during anhepatic phase of liver transplantation
total vecuronium requirements as guided by Train-of-four neuromuscular monitoring during anhepatic phase
Time frame: during neohepatic phase of liver transplantation
total vecuronium requirements as guided by Train-of-four neuromuscular monitoring during neohepatic phase
Samsung Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728604
Behavior, Health Behavior
Izmir, Turkey (Türkiye)
View Trial DetailsNCT01294020
Heart Transplantation, Intestine Transplantation
Brussels, Belgium
View Trial DetailsNCT07233083
Liver Transplantation, Neurologic Manifestations
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07233096
Liver Transplantation, Living Donor
Istanbul, Turkey (Türkiye)
View Trial Details